PCN80 Modelling the Cost-Effectiveness of Ipilimumab for Previously-Treated, Metastatic Melanoma
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2120
https://www.valueinhealthjournal.com/article/S1098-3015(12)03834-X/fulltext
Title :
PCN80 Modelling the Cost-Effectiveness of Ipilimumab for Previously-Treated, Metastatic Melanoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03834-X&doi=10.1016/j.jval.2012.08.2120
First page :
A423
Section Title :
Cancer
Open access? :
No
Section Order :
773